Literature DB >> 21923247

Prospective evaluation of the characteristics and incidence of adenoma-associated dural invasion in Cushing disease.

Russell R Lonser1, Alexander Ksendzovsky, Joshua J Wind, Alexander O Vortmeyer, Edward H Oldfield.   

Abstract

OBJECT: Dural invasion by adrenocorticotropic hormone (ACTH)-secreting adenomas is a significant risk factor for incomplete resection and recurrence in Cushing disease (CD). Since ACTH-producing adenomas are often the smallest of the various types of pituitary tumors at the time of resection, examining their invasion provides the best opportunity to identify the precise sites of early dural invasion by pituitary adenomas. To characterize the incidence and anatomical distribution of dural invasion by ACTH-secreting adenomas, the authors prospectively and systematically analyzed features of dural invasion in patients with CD.
METHODS: The authors prospectively studied consecutive patients with CD undergoing the systematic removal of ACTH-secreting adenoma and histological analysis of the anterior sella dura as well as other sites of dural invasion that were evident at surgery. Clinical, imaging, histological, and operative findings were analyzed.
RESULTS: Eighty-seven patients with CD (58 females and 29 males) were included in the study. Overall, dural invasion by an ACTH-positive adenoma was histologically confirmed in 30 patients (34%). Eighteen patients (60% of dural invasion cases, 21% of all patients) had evidence of cavernous sinus wall invasion (4 of these patients also had other contiguous sites of invasion), and 12 patients (40% of dural invasion cases) had invasion of the sella dura excluding the cavernous sinus wall. Eleven patients (13% all patients) had invasion of the routinely procured anterior sella dura specimen. Preoperative MR imaging revealed an adenoma in 64 patients (74%) but accurately predicted dural invasion in only 4 patients (22%) with cavernous sinus invasion and none of the patients with non-cavernous sinus invasion. Adenomas associated with dural invasion (mean ± SD, 10.9 ± 7.8 mm, range 2-37 mm) were significantly larger than those not associated with dural invasion (5.7 ± 2.1 mm, range 2.5-12 mm; p = 0.0006, Mann-Whitney test).
CONCLUSIONS: Dural invasion by ACTH-producing adenomas preferentially occurs laterally into the wall of the cavernous sinus. Preoperative MR imaging infrequently detects dural invasion, including cavernous sinus invasion. Invasion is directly associated with tumor size. To provide a biochemical cure and avoid recurrence after resection, identification and removal of invaded sella dura, including the medial cavernous sinus wall, are necessary.

Entities:  

Mesh:

Year:  2011        PMID: 21923247      PMCID: PMC4762047          DOI: 10.3171/2011.8.JNS11456

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  22 in total

1.  Surgical remission of pituitary adenomas confined to the neurohypophysis in Cushing's disease.

Authors:  Robert J Weil; Alexander O Vortmeyer; Lynnette K Nieman; Hetty L Devroom; John Wanebo; Edward H Oldfield
Journal:  J Clin Endocrinol Metab       Date:  2006-04-24       Impact factor: 5.958

2.  Outcome of using the histological pseudocapsule as a surgical capsule in Cushing disease.

Authors:  Jay Jagannathan; Rene Smith; Hetty L DeVroom; Alexander O Vortmeyer; Constantine A Stratakis; Lynnette K Nieman; Edward H Oldfield
Journal:  J Neurosurg       Date:  2009-09       Impact factor: 5.115

3.  Spoiled gradient recalled acquisition in the steady state technique is superior to conventional postcontrast spin echo technique for magnetic resonance imaging detection of adrenocorticotropin-secreting pituitary tumors.

Authors:  Nicholas Patronas; Nail Bulakbasi; Constantine A Stratakis; Antony Lafferty; Edward H Oldfield; John Doppman; Lynnette K Nieman
Journal:  J Clin Endocrinol Metab       Date:  2003-04       Impact factor: 5.958

4.  Early repeat surgery for persistent Cushing's disease.

Authors:  Z Ram; L K Nieman; G B Cutler; G P Chrousos; J L Doppman; E H Oldfield
Journal:  J Neurosurg       Date:  1994-01       Impact factor: 5.115

5.  Detection of adrenocorticotropin-secreting pituitary adenomas by magnetic resonance imaging in children and adolescents with cushing disease.

Authors:  Dalia Batista; Nickolas A Courkoutsakis; Edward H Oldfield; Kurt J Griffin; Meg Keil; Nickolas J Patronas; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2005-06-07       Impact factor: 5.958

6.  Invasiveness of pituitary adenomas.

Authors:  D Sautner; W Saeger
Journal:  Pathol Res Pract       Date:  1991-06       Impact factor: 3.250

7.  Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome.

Authors:  E H Oldfield; J L Doppman; L K Nieman; G P Chrousos; D L Miller; D A Katz; G B Cutler; D L Loriaux
Journal:  N Engl J Med       Date:  1991-09-26       Impact factor: 91.245

8.  Pituitary adenomas with parasellar invasion.

Authors:  E Knosp; K Kitz; E Steiner; C Matula
Journal:  Acta Neurochir Suppl (Wien)       Date:  1991

Review 9.  Approach to the patient with possible Cushing's syndrome.

Authors:  Marco Boscaro; Giorgio Arnaldi
Journal:  J Clin Endocrinol Metab       Date:  2009-09       Impact factor: 5.958

10.  Basis of persistent and recurrent Cushing disease: an analysis of findings at repeated pituitary surgery.

Authors:  Rob D Dickerman; Edward H Oldfield
Journal:  J Neurosurg       Date:  2002-12       Impact factor: 5.115

View more
  12 in total

Review 1.  Surgical management of Cushing's disease.

Authors:  Robert F Dallapiazza; Edward H Oldfield; John A Jane
Journal:  Pituitary       Date:  2015-04       Impact factor: 4.107

Review 2.  Is there a role for early chemotherapy in the management of pituitary adenomas?

Authors:  Andrew L Lin; Melissa W Sum; Lisa M DeAngelis
Journal:  Neuro Oncol       Date:  2016-04-21       Impact factor: 12.300

3.  Dural Invasion as a Marker of Aggressive Pituitary Adenomas.

Authors:  Odelia Cooper; Vivien Bonert; Adam N Mamelak; Serguei Bannykh; Shlomo Melmed
Journal:  Neurosurgery       Date:  2022-03-11       Impact factor: 5.315

4.  Absence of immunostaining for growth hormone in a subset of patients with acromegaly.

Authors:  Jason L Schroeder; Alejandro M Spiotta; Maria Fleseriu; Richard A Prayson; Amir H Hamrahian; Robert J Weil
Journal:  Pituitary       Date:  2014-04       Impact factor: 4.107

5.  Outcome of surgical treatment of 200 children with Cushing's disease.

Authors:  Russell R Lonser; Joshua J Wind; Lynnette K Nieman; Robert J Weil; Hetty L DeVroom; Edward H Oldfield
Journal:  J Clin Endocrinol Metab       Date:  2013-01-31       Impact factor: 5.958

6.  Endosphenoidal coil for intraoperative magnetic resonance imaging of the pituitary gland during transsphenoidal surgery.

Authors:  Prashant Chittiboina; S Lalith Talagala; Hellmut Merkle; Joelle E Sarlls; Blake K Montgomery; Martin G Piazza; Gretchen Scott; Abhik Ray-Chaudhury; Russell R Lonser; Edward H Oldfield; Alan P Koretsky; John A Butman
Journal:  J Neurosurg       Date:  2016-03-18       Impact factor: 5.115

7.  Magnetic resonance imaging criteria to predict complete excision of parasellar pituitary macroadenoma on postoperative imaging.

Authors:  S E J Connor; F Wilson; K Hogarth
Journal:  J Neurol Surg B Skull Base       Date:  2013-08-21

Review 8.  Surgical and radiosurgical treatment strategies for Cushing's disease.

Authors:  Adomas Bunevicius; Edward R Laws; Mary Lee Vance; Sherry Iuliano; Jason Sheehan
Journal:  J Neurooncol       Date:  2019-11-01       Impact factor: 4.130

9.  Transsphenoidal Surgery of Corticotroph Adenomas With Cavernous Sinus Invasion: Results in a Series of 86 Consecutive Patients.

Authors:  Congxin Dai; Ming Feng; Lin Lu; Bowen Sun; Yanghua Fan; Xinjie Bao; Yong Yao; Kan Deng; Renzhi Wang; Jun Kang
Journal:  Front Oncol       Date:  2022-02-08       Impact factor: 6.244

10.  A rare case of multiple pituitary adenomas in an adolescent Cushing disease presenting as a vertebral compression fracture.

Authors:  Ji-Yeon Song; Sue-Jean Mun; Soon-Ki Sung; Jae-Yeon Hwang; Seung-Kug Baik; Jee Yeon Kim; Chong-Kun Cheon; Su-Young Kim; Yoo-Mi Kim
Journal:  Ann Pediatr Endocrinol Metab       Date:  2017-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.